These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12705741)

  • 1. Cutaneous T-cell lymphoma.
    Kotz EA; Anderson D; Thiers BH
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):131-7. PubMed ID: 12705741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.
    Miyagaki T; Sugaya M
    J Dermatol Sci; 2011 Oct; 64(1):1-6. PubMed ID: 21872448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
    Burg G; Häffner A; Böni R; Dommann S; Dummer R
    Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with erythroderma and pruritus: Sézary syndrome].
    Overweel AFP; Langerak AW; Damman J; de Haas ELM; Weerkamp F; Sandberg Y
    Ned Tijdschr Geneeskd; 2022 Feb; 166():. PubMed ID: 35499588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone.
    Trotter MJ; Whittaker SJ; Orchard GE; Smith NP
    J Cutan Pathol; 1997 May; 24(5):286-91. PubMed ID: 9194581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of cutaneous T-cell lymphomas].
    Rappersberger K; Ortel B; Forstinger C; Wolff K
    Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T cell lymphoma in children.
    Garzon MC
    Semin Cutan Med Surg; 1999 Sep; 18(3):226-32. PubMed ID: 10468042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrodermic CTCL: updated clues to diagnosis and treatment.
    Bernengo MG; Quaglino P
    G Ital Dermatol Venereol; 2012 Dec; 147(6):533-44. PubMed ID: 23149699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy of cutaneous T-cell lymphoma (CTCL).
    Alpdogan O; Kartan S; Johnson W; Sokol K; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):10. PubMed ID: 30818958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma.
    Moriarty B; Whittaker S
    Expert Rev Hematol; 2015 Apr; 8(2):159-71. PubMed ID: 25495961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
    Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB
    CNS Oncol; 2023 Dec; 12(4):CNS105. PubMed ID: 37877303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.